VAERS Explorer
Back to explore

Report #2883986

Received Feb 3, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
KY
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNK—OT

Symptoms (1)

Injection site reaction

Symptom narrative

injection site reactions, which had occurred on day 1, and worsened on the next day; This spontaneous report was received from a nurse practitioner via Company representative and refers to an adult patient (in their 50s) of unknown gender. The patient's medical history, concurrent conditions, past medications and concomitant medications were not reported. On an unknown date, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) solution for injection, intramuscularly (exact dose, dose number, anatomical location, lot# and expiry date were not reported), for pneumococcal prevention. On an unspecified date, the patient experienced injection site reaction, which occurred on day 1, and worsened on the next day. The outcome of the event was not provided. The action taken with the suspect vaccine regarding the event was not reported but assessed as not applicable. The causality assessment between event and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not provided. The reporter considered vaccination site reaction to be non-serious event. This is one of two reports from the same reporter.